06 Nov Targeting MAP kinase ERK5 to upregulate MHC-I in cancer cells: a new strategy to sensitize tumors to CD8+ T lymphocytes?

Posted at 15:18h in INMUNOTHERAPY by

ID: 03275

Authors: Viñas-Casas, Maria (1,2); Lizcano, Jose M (1,2)

Topic: INMUNOTHERAPY